← Leaderboards
Chelsea Dawn Landon
Duke University
$302,578
Attributed
$302,578
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $117.2K · FY2011–21$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$302,578 · 2
By mechanism
K01$234,442 · 1
F31$68,136 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Ashutosh Chilkoti$32,367,884
- John Andrew Mackay$5,232,024
- Mark Wesley Dewhirst$12,821,035
- Everett H Ellinwood$4,203,697
- Xiao-Fan Wang$23,927,835
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseAdjuvantMalignant NeoplasmsBaseCancer TherapyCancer CellDrug Delivery SystemsEnvironmentSiteTumorNeoplasm MetastasisEffective TherapyBlood VesselsBladderAntigensBiological PreservationBiodistributionAnti-Ctla4Adjuvant ChemotherapyCd8b1 GeneCarrier ProteinsCareerCd8-Positive T-LymphocytesCancer Vaccines
Grant awards (5)
Utilizing intranasal immunization to induce a cytotoxic T lymphocyte response and reduce metastatic burden in the lung$117,221
K01 · FY2021 · OD · contact PI
Utilizing intranasal immunization to induce a cytotoxic T lymphocyte response and reduce metastatic burden in the lung$117,221
K01 · FY2020 · OD · contact PI
The Use of Hyperthermia and Copper Chelation to Overcome Cisplatin Resistance$2,186
F31 · FY2013 · AT · contact PI
The Use of Hyperthermia and Copper Chelation to Overcome Cisplatin Resistance$33,191
F31 · FY2012 · AT · contact PI
The Use of Hyperthermia and Copper Chelation to Overcome Cisplatin Resistance$32,759
F31 · FY2011 · AT · contact PI